Provider review
Remi Meds review
The price falls at the low doses, and the whole ladder is on the homepage.
A quarter dose costs 29% less here than a full one, and you can check that before handing over anything. The catch is that the page never tells you which drug you are buying.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Remi Meds
$249/mo semaglutide at 0.25–0.5 mg/week, $349 at 1 mg and up
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take a quarter dose here and it costs you less — 29% less than the rungs at a full milligram and above — and you can confirm that on the homepage without a quiz, an email address or an account. Five rungs for each molecule, each printing a weekly milligram against a monthly price, is the clearest answer to the cost-per-dose question anywhere here. Everything is billed monthly with no prepay rungs and no first-month teaser, so the number you see is the number you pay. Two things will cost you. The rendered pages never actually name the molecule — you are buying something called a personalized GLP-1, and which drug that is has to be inferred from the ladder and the page address. And the outcome claims are printed as product bullets with no study, duration or population attached, so treat them as marketing rather than as evidence.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You intend to hold a low weekly dose and want the price to reflect it
- You want to see the milligram against the price before giving anyone your email address
- You want a plain monthly bill with no prepay commitment and no first-month teaser
- You want the prescribing network named
Look elsewhere if
- You want the molecule named in plain words on the page you buy from
- You expect to titrate up. The price steps up with you, and the tirzepatide ladder steps four times
- You want the dispensing pharmacy named, or a list of the states served
- You are weighing the outcome claims. They are printed as bullets, not as trial findings
What it actually costs
Price as published
Priced by dose, "Billed monthly" (stated twice) · semaglutide $249/month at 0.25 and 0.5 mg per week, $349/month at 1, 1.7 and 2.4 mg · tirzepatide with B12 $349/month at 2.25 and 4.5 mg, $449 at 6.75 mg, $549 at 9 mg, $649 at 11.25 mg · the entry rung is labeled "~ starting dose" · no intro price and no prepay rungs · the rendered copy never names semaglutide or tirzepatide — the products are "Personalized GLP-1" and "Personalized GLP-1/GIP +B12", identifiable only from the milligram ladders and the molecule named in the URLs · sermorelin and NAD+ rungs are quoted in milliliters, not milligrams
- Vs median
- $80/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. Price follows dose in published steps: the two lowest weekly milligram rungs cost 29% less than every rung above them, and the tirzepatide ladder rises across four steps. A reader holding a quarter dose can price it before signing up, which is the exception here rather than the rule.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Publishes a complete milligram-per-week price ladder for both molecules on the homepage with no quiz required — the most direct answer here to what a quarter dose costs
- The low end is real money saved: the two lowest weekly rungs cost 29% less than every rung at 1 mg and above
- Prices the starting dose lowest and labels it "~ starting dose", so the entry rung is unambiguous
- "Billed monthly" stated plainly, with no prepay rungs dressed up as monthly rates and no first-month teaser
- Names its prescribing network — "partners with independent licensed physician networks, including Beluga Health" — and publishes a LegitScript ID, 44499538
Pharmacy, labs and oversight
Remi Meds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Remi Meds publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Remi Meds prices its GLP-1 plans by milligrams per week and publishes the whole ladder on its homepage under "Dosage Options" — five rungs for each molecule, each with a weekly milligram figure against a monthly price, with no quiz or account in the way. Everything is billed monthly, with no intro rate and no prepay rungs. It also sells sermorelin and NAD+, quoted in milliliters rather than milligrams. It names its prescribing network and publishes a LegitScript ID, but names no pharmacy and publishes no state list.
The honest cons
THE RENDERED COPY NEVER NAMES THE MOLECULE. What you buy is "Personalized GLP-1" or "Personalized GLP-1/GIP +B12"; which drug that is can only be inferred from the milligram ladder and the page address
- The sermorelin and NAD+ rungs are quoted in milliliters rather than milligrams — "SERMORELIN 3 ml per week | $249/mo" — so those ladders carry no dose information at all
- "Achieve up to 15% body weight reduction" and "up to 25%" are printed as product bullets rather than as trial findings, with no study, duration or population attached
- The comparison table asserts "Minimize Nausea" and "Less Side effects" as features Remi's plans have and others do not, which is not a checkable claim
- No compounding pharmacy is named — only "our trusted pharmacy partners" — and no list of states served is published
- No week count is published behind "Billed monthly"
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Remi Meds is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#128 of 373
Ordered with the companies that pay us first, and Remi Meds is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.